Roche is more than doubling its total commitment to a future facility for its Genentech unit to approximately $2 billion. The plant, being built in Holly Springs, North Carolina, will be used to crank out next-generation drugs for metabolic conditions like obesity, Roche has said.
Roche scales Genentech’s North Carolina site to $2B in major obesity market play
Latest from Blog
Minnesota reaches $18.5 million settlement with nonprofit over child nutrition fraud claims
Partners in Nutrition will dissolve and turn over remaining funds under a consent judgment filed in Hennepin County Post Views: 3
Caitlin Clark turns cereal into a $100,000+ fundraiser: How the WNBA superstar used her platform to support youth programmes away from basketball
Caitlin Clark’s rise has translated off the court as the Indiana Fever star has made more of herself through commercial partnerships and community endeavors. One of the more unique examples has been
The Healthiest Vegetables to Add to Your Grocery List, According to Dietitians
Fresh or frozen, these veggies are a simple way to add fiber and essential vitamins to your diet. Post Views: 3
